Impact of Dairy Products on Postprandial Inflammation
Not Applicable
Completed
- Conditions
- ObesityInflammationNutritional Intervention
- Interventions
- Other: consumption of high fat test meal with dairy productsOther: consumption of high fat test meal without dairy productsOther: consumption of test meal based on dairy products
- Registration Number
- NCT01885416
- Lead Sponsor
- Agroscope Liebefeld-Posieux Research Station ALP
- Brief Summary
The study will quantitatively evaluate the systemic, postprandial inflammatory and metabolic response to the ingestion of three different meals in obese subjects. The administered meals will differ in the proportion of dairy products. Postprandial response will be monitored during 6 hours after meal consumption.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 21
Inclusion Criteria
- male
- BMI ≥ 20 kg/m2
- age 25-55 y
- informed consent
Exclusion Criteria
- Physiological or psychological diseases
- Allergies to food or intolerance to high-fat meal
- Vegetarians
- Chronic intake of drugs
- Smokers
- Diabetes mellitus Type I and II
- Debilitating kidney diseases
- Debilitating liver diseases
- Clinically established coronary heart diseases
- Ingestion of vitamins or dietary supplements during the course of the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description high fat meal with additional milk consumption of high fat test meal with dairy products high fat meal with additional milk high fat meal without dairy products consumption of high fat test meal without dairy products high fat meal without dairy products dairy product meal consumption of test meal based on dairy products dairy product meal
- Primary Outcome Measures
Name Time Method Inflammation markers in blood plasma (IL-6, TNF-alpha) 0,6h
- Secondary Outcome Measures
Name Time Method Biomarkers in blood (serum insulin, plasma glucose, GLP-1, lipids) 0,1,2,4,6h Endotoxin in blood serum 0,6h
Trial Locations
- Locations (1)
University Hospital, Inselspital Berne
🇨🇭Bern, Switzerland